These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8673791)

  • 1. Thrombolysis "door-to-drug" interval.
    Mayer T
    Acad Emerg Med; 1996 Mar; 3(3):285-6; author reply 286-7. PubMed ID: 8673791
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors influencing the time to thrombolysis in acute myocardial infarction. Time to Thrombolysis Substudy of the National Registry of Myocardial Infarction-1.
    Lambrew CT; Bowlby LJ; Rogers WJ; Chandra NC; Weaver WD
    Arch Intern Med; 1997 Dec 8-22; 157(22):2577-82. PubMed ID: 9531226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Answering the hard questions about thrombolysis.
    Socransky S
    CMAJ; 1998 Jun; 158(12):1600; author reply 1602. PubMed ID: 9645170
    [No Abstract]   [Full Text] [Related]  

  • 4. Time to thrombolysis in patients with acute myocardial infarction in a tertiary referral centre: an important performance indicator in an emergency department.
    Shahane K; Mehta SS; Gogtay NJ; Kshirsagar NA
    J Assoc Physicians India; 2006 Jan; 54():78-80. PubMed ID: 16649746
    [No Abstract]   [Full Text] [Related]  

  • 5. Starting thrombolytic therapy for patients with acute myocardial infarction in Accident and Emergency Department: from implementation to evaluation.
    Chan WK; Lam KN; Lau FL; Tang HM
    Chin Med J (Engl); 1998 Apr; 111(4):291-4. PubMed ID: 10374389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolysis "door-to-drug" interval.
    Walls RM; Cannon CP; Teich J
    Acad Emerg Med; 1996 Mar; 3(3):285; author reply 286-7. PubMed ID: 8673790
    [No Abstract]   [Full Text] [Related]  

  • 7. Application of Lean Six Sigma for patients presenting with ST-elevation myocardial infarction: the Hamilton Health Sciences experience.
    Aldarrab A
    Healthc Q; 2006; 9(1):56-61, 2. PubMed ID: 16548435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Answering the hard questions about thrombolysis.
    Yusuf SW
    CMAJ; 1998 Jun; 158(12):1601-2. PubMed ID: 9645172
    [No Abstract]   [Full Text] [Related]  

  • 9. An evaluation of door to needle time (DNT) of thrombolytic therapy following acute myocardial infarction in three large tertiary referral hospitals in Dhaka City.
    Muqueet MA; Sirajul Haque KM; Faruque GM; Hossain M; Khan RJ; Mahmood M; Ounpuu S; Yusuf S
    Bangladesh Med Res Counc Bull; 2006 Apr; 32(1):29-34. PubMed ID: 17665831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The delay to thrombolysis: an analysis of hospital and patient characteristics. Quebec Acute Coronary Care Working Group.
    Brophy JM; Diodati JG; Bogaty P; Théroux P
    CMAJ; 1998 Feb; 158(4):475-80. PubMed ID: 9627559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality Q & A. Question: how can you sell the principles of CQI or TQM to an organization that does not see the value (monetary) of these activities?
    Green E
    Nurs Qual Connect; 1995; 4(4):6. PubMed ID: 7767302
    [No Abstract]   [Full Text] [Related]  

  • 12. Door-to-needle time in myocardial infarction: is there an ideal benchmark?
    Canto JG; Kiefe CI
    Am Heart J; 2005 Sep; 150(3):365-7. PubMed ID: 16169308
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of acute myocardial infarction in scarsely populated areas in Norrland. Thrombolysis at cottage hospitals saves a lot of time].
    Hansson N; Bjurman A; Westman G
    Lakartidningen; 1995 Jun; 92(26-27):2657-60. PubMed ID: 7637443
    [No Abstract]   [Full Text] [Related]  

  • 14. Door to needle time in administering thrombolytic therapy for acute myocardial infarction.
    Abba AA; Wani BA; Rahmatullah RA; Khalil MZ; Kumo AM; Ghonaim MA
    Saudi Med J; 2003 Apr; 24(4):361-4. PubMed ID: 12754534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency department thrombolysis critical pathway reduces door-to-drug times in acute myocardial infarction.
    Cannon CP; Johnson EB; Cermignani M; Scirica BM; Sagarin MJ; Walls RM
    Clin Cardiol; 1999 Jan; 22(1):17-20. PubMed ID: 9929749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency physician versus cardiologist-initiated thrombolysis for acute myocardial infarction: a Singapore experience.
    Irwani I; Seet CM; Manning PG
    Singapore Med J; 2004 Jul; 45(7):313-7. PubMed ID: 15221046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary thrombolysis in community centres and emergency rooms.
    Johnstone D
    Can J Cardiol; 1993; 9(6):522-3. PubMed ID: 8221349
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolysis for acute myocardial infarction in Australasia 1999.
    Mountain D; Jelinek GA; O'Brien DL; Ingarfield SL; Jacobs IG; Lynch DM
    Emerg Med (Fremantle); 2002 Sep; 14(3):267-74. PubMed ID: 12487044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergency department triage of acute myocardial infarction patients and the effect on outcomes.
    Atzema CL; Austin PC; Tu JV; Schull MJ
    Ann Emerg Med; 2009 Jun; 53(6):736-45. PubMed ID: 19157653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of continuous quality improvement analysis on the delivery of primary percutaneous revascularization for acute myocardial infarction: a community hospital experience.
    Caputo RP; Kosinski R; Walford G; Giambartolomei A; Grant W; Reger MJ; Simons A; Esente P
    Catheter Cardiovasc Interv; 2005 Apr; 64(4):428-33; discussion 434-5. PubMed ID: 15789395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.